Utvalgte publikasjoner

Publikasjoner

• Gerdes S, Schoppmann SF, Bonavina L3, Boyle N, Müller-Stich BP, Gutschow CA; Hiatus Hernia Delphi Collaborative Group (incl Søvik T) . Management of paraesophageal hiatus hernia: recommendations following a European expert Delphi consensus. Surg Endosc. 2023.
• de Jongh C, Cianchi F, Kinoshita T, Kingma F, Piccoli M, Dubecz A, Kouwenhoven E, van Det M, Mala T, Coratti A, Ubiali P, Turner P, Kish P, Borghi F, Immanuel A, Nilsson M, Rouvelas I, Hӧlzen JP, Rouanet P, Saint-Marc O, Dussart D, Patriti A, Bazzocchi F, van Etten B, Haveman JW, DePrizio M, Sabino F, Viola M, Berlth F, Grimminger PP, Roviello F, van Hillegersberg R, Ruurda J; UGIRA Collaborative Group (incl Førland D). Surgical Techniques and Related Perioperative Outcomes After Robot-assisted Minimally Invasive Gastrectomy (RAMIG): Results From the Prospective Multicenter International Ugira Gastric Registry. Ann Surg 2023.
• Evensen E, Sandstad O3, Larssen L3, Hagen M, Kristensen V3, Søvik TT, Schulz T, Hauge T, Medhus AW.  Intraoperative distensibility measurement in POEM for achalasia: impact on patient outcome and associations with other outcome variables at 1-year follow-up. Surg Endosc 2023 epub ahead of print.
• Anundsen T, Førland D, Johannessen HO, Johnson E. Outcome after stent and endoscopic vacuum therapy-based treatment for postemetic esophageal rupture. Scand J Gastroenterol. 2023; 17:1-6.
• Nilsson K, Klevebro F, Sunde B, Rouvelas I, Lindblad M, Szabo E, Halldestam I, Smedh U, Wallner B, Johansson J, Johnsen G, Aahlin EK, Johannessen HO, Alexandersson von Döbeln G, Hjortland GO, Wang N, Shang Y, Borg D, Quaas A, Bartella I, Bruns C, Schröder W, Nilsson M. Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre randomised controlled NeoRes II trial. Ann Oncol. 2023:S0923-7534(23)00825-6.
• Venizelos A, Sorbye H, Elvebakken H, Perren A, Lothe IMB, Couvelard A, Hjortland GO, Sundlöv A, Svensson J, Garresori H, Kersten C, Hofsli E, Detlefsen S, Vestermark LW, Ladekarl M, Tabaksblat EM, Knappskog S. Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat Cancer. 2023 Aug 23;30(10):e230057
• Elvebakken H, Hjortland GO, Garresori H, Andresen PA, Janssen EAM, Vintermyr OK, Lothe IMB, Sorbye H. Impact of KRAS and BRAF mutations on treatment efficacy and survival in high-grade gastroenteropancreatic neuroendocrine neoplasms. J Neuroendocrinol. 2023 Apr;35(4):e13256.
• Saeed U, Nordsletten M, Myklebust TÅ, Robsahm TE, Møller B, Skålhegg BS, Mala T, Yaqub S. Cancer risk and survival according to body mass index in hepatobiliary malignancies: a nationwide registry-based cohort study. HPB (Oxford). 2023 Jul 17:S1365-182X(23)01868-3.
• Nordsletten M, Saeed U, Myklebust TÅ, Robsahm TE, Møller B, Skålhegg BS, Mala T, Yaqub S. Body mass index and its association with 22 cancer types: a Norwegian cohort study of 481 202 cancer cases. Acta Oncol. 2023 Sep 15:1-6.
• Kazaryan AM, Monrad-Hansen PW, Eftang LL, Hagve M, Nedrebø BS, Rancinger P, Mala T. Perioperative antibiotic prophylaxis and interval appendectomy. Tidsskr Nor Laegeforen. 2023 8;143(7).
• Saeed U, Myklebust TÅ, Robsahm TE, Kielland MF, Møller B, Skålhegg BS, Mala T, Yaqub S. Risk and survival in colorectal cancer with increasing body mass index: A nationwide population-based cohort study. Colorectal Dis. 2023 Mar;25(3):375-385.
• Saeed U, Myklebust TÅ, Robsahm TE, Møller B, Mala T, Skålhegg BS, Yaqub S. Body mass index and pancreatic adenocarcinoma: A nationwide registry-based cohort study. Scand J Surg. 2023 Mar;112(1):11-21
• Morken S, Langer SW, Sundlöv A, Vestermark LW, Ladekarl M, Hjortland GO, Svensson JB, Tabaksblat EM, Haslerud TM, Assmus J, Detlefsen S, Couvelard A, Perren A, Sorbye H. Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms. Br J Cancer. 2023 Online ahead of print.
• Knappskog S, Grob T, Venizelos A, Amstutz U, Hjortland GO, Lothe IM, Kersten C, Hofsli E, Sundlöv A, Elvebakken H, Garresori H, Couvelard A, Svensson J, Sorbye H, Perren A. Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma. JCO Precis Oncol. 2023 Feb;7:e2200336.
• Fasting MH, Strønen E, Glomsaker T, Søvik TT, Fyhn TJ, Mala T. Perioperative strategies for patients undergoing subtotal cholecystectomy: a single-center retrospective review of 102 procedures. Scand J Gastroenterol. 2023 Dec 5:1-5.
• Chiappetta S, Stier C, Ghanem OM, Dayyeh BKA, Boškoski I, Prager G, LaMasters T, Kermansaravi M; PGEMU collaborators. (incl Mala T). Perioperative Interventions to Prevent Gastroesophageal Reflux Disease and Marginal Ulcers After Bariatric Surgery - an International Experts' Survey. Obes Surg. 2023;33:1449-1462.
• A national precision cancer medicine implementation initiative for Norway. Taskén K, et al. Nat Med. 2022.
• Short- and long-term outcomes in patients operated with total minimally invasive esophagectomy for esophageal cancer. Hauge T, et al. Dis Esophagus. 2022.
• Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial. Nilsson M, et al. Front Oncol. 2022.
• Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway. Helland Å et al. J Transl Med. 2022.
• Volumetric parameters from [18 F]FDG PET/CT predicts survival in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms. Stokmo HL, J Neuroendocrinol. 2022.
• Predicting satisfaction with outcome and follow-up care 5 years after bariatric surgery: A prospective evaluation. Kvalem IL, et al. Obes Sci Pract. 2022.
• Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett's esophagus. Pinto R, et al. Clin Epigenetics. 2022.
• Quality of life in patients with achalasia: Associations with Eckardt score and objective treatment outcomes after peroral endoscopic myotomy. Evensen H, et al. Endosc Int Open. 2022.
• Early experience with total robotic D2 gastrectomy in a low incidence region: surgical perspectives. Mala T, et al.. BMC Surg. 2022.
• International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study). Arnold M, et al. Gut. 2022.
• Partial splenectomy after preoperative embolization in a patient with metastatic melanoma - A case report. Hauge T, et al. Int J Surg Case Rep. 2022.
• Gastroscopy following vertical sleeve gastrectomy. Mala T et al. Tidsskr Nor Laegeforen. 2022.